Steigerwald, Gordon & Koch Inc. Merck & Co., Inc. Transaction History

Steigerwald, Gordon & Koch Inc.

$908 Million
Q3 2024

A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 5,829 shares of MRK stock, worth $580,102. This represents 0.07% of its overall portfolio holdings.

Number of Shares

5,829

Previous 5,186 12.4%

Holding current value

$580,102

Previous $642,000 2.96%

% of portfolio

0.07%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$111.15 - $128.97 $71,469 - $82,927	643 Added 12.4%	5,829 $661,000
Q2 2024 Aug 07, 2024	BUY	$123.8 - $132.96 $17,332 - $18,614	140 Added 2.77%	5,186 $642,000
Q1 2024 Apr 16, 2024	BUY	$113.24 - $131.95 $7,813 - $9,104	69 Added 1.39%	5,046 $665,000
Q4 2023 Jan 16, 2024	SELL	$100.18 - $109.02 $111,901 - $121,775	-1,117 Reduced 18.33%	4,977 $542,000
Q3 2023 Oct 11, 2023	BUY	$102.95 - $114.33 $29,134 - $32,355	283 Added 4.87%	6,094 $627,000
Q2 2023 Jul 17, 2023	BUY	$108.61 - $118.38 $32,474 - $35,395	299 Added 5.42%	5,811 $670,000
Q1 2023 Apr 19, 2023	BUY	$102.94 - $114.86 $18,838 - $21,019	183 Added 3.43%	5,512 $586,000
Q4 2022 Jan 17, 2023	BUY	$87.44 - $112.11 $28,243 - $36,211	323 Added 6.45%	5,329 $0
Q3 2022 Oct 12, 2022	BUY	$84.53 - $94.96 $1,437 - $1,614	17 Added 0.34%	5,006 $431,000
Q2 2022 Jul 14, 2022	BUY	$83.49 - $94.64 $68,712 - $77,888	823 Added 19.76%	4,989 $455,000
Q1 2022 Apr 25, 2022	BUY	$73.51 - $82.4 $5,219 - $5,850	71 Added 1.73%	4,166 $342,000
Q4 2021 Jan 26, 2022	SELL	$72.28 - $90.54 $16,407 - $20,552	-227 Reduced 5.25%	4,095 $314,000
Q3 2021 Oct 18, 2021	BUY	$71.68 - $78.83 $5,447 - $5,991	76 Added 1.79%	4,322 $325,000
Q2 2021 Jul 27, 2021	SELL	$70.31 - $77.77 $3,304 - $3,655	-47 Reduced 1.09%	4,246 $330,000
Q1 2021 Apr 27, 2021	BUY	$68.86 - $81.11 $10,329 - $12,166	150 Added 3.62%	4,293 $331,000
Q4 2020 Jan 22, 2021	BUY	$71.77 - $79.65 $56,554 - $62,764	788 Added 23.49%	4,143 $339,000
Q3 2020 Oct 14, 2020	SELL	$73.18 - $82.95 $3,585 - $4,064	-49 Reduced 1.44%	3,355 $278,000
Q2 2020 Jul 14, 2020	BUY	$70.42 - $80.13 $11,548 - $13,141	164 Added 5.06%	3,404 $263,000
Q1 2020 Apr 20, 2020	SELL	$63.36 - $87.82 $4,688 - $6,498	-74 Reduced 2.23%	3,240 $249,000
Q4 2019 Jan 27, 2020	BUY	$77.58 - $87.54 $50,349 - $56,813	649 Added 24.35%	3,314 $301,000
Q3 2019 Oct 30, 2019	BUY	$76.08 - $82.93 $76 - $82	1 Added 0.04%	2,665 $224,000
Q2 2019 Jul 15, 2019	BUY	$69.84 - $81.59 $186,053 - $217,355	2,664 New	2,664 $223,000
Q3 2017 Sep 14, 2018	SELL	$58.67 - $63.13 $207,281 - $223,038	-3,533 Closed	0 $0
Q2 2017 Sep 13, 2018	BUY	N/A	3,533	3,533 $226,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steigerwald, Gordon & Koch Inc., based on Form 13F filings with the SEC.

News

Stay updated on Steigerwald, Gordon & Koch Inc. with notifications on news.

Account

Steigerwald, Gordon & Koch Inc. Merck & Co., Inc. Transaction History